📰 Beyond Intervention News
Beyond Intervention News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Beyond Intervention. Real-time updates on events, politics, business and more.
March 24, 2023
The latest post-procedure experience report from Abbott reveals challenges resulting from a systemic lack of adoption of consumer…
February 26, 2023
This week in Healthcare Digital, we looked at telehealth supporting menopausal women, AI technology in healthcare & Abbott’s digital health data
February 23, 2023
Abbott’s Beyond Intervention data shows that digital health tools can improve the patient experience, with 60% saying they would trust AI to make diagnosis
August 8, 2022
Earlier this year, Abbott's (NYSE:ABT) vascular business released a supplement on gender and racial biases in cardiovascular care.
June 27, 2022
Achieving greater gender equity in healthcare is about making systemic changes on a comprehensive scal
April 13, 2022
The FDA today issued a new draft guidance outlining plans for increased diversity in clinical trials in the U.S.
November 27, 2021
Abbott released a white paper outlining the findings of its global market research initiative, Beyond Intervention, designed to assess the vascular patient experience from the perspectives of patients, physicians and health care leaders. According to the white paper, the Beyond Intervention survey included 1,289 people with CVD in 13 countries, as well as 408 physicians and 173 health care
August 4, 2021
Search jobs 04-Aug-2021 Abbott Receives FDA Clearance For Its Imaging Technology Using Artificial Intelligence For Vessels in the Heart - Ultreon™ 1.0 Software, the first-of-its-kind imaging software, merges optical coherence tomography with the power of automation using Artificial Intelligence - The new intuitive interface provides step-by-step guidance to enhance ease of use - When combined with Abbotts Dragonfly OpStar™ imaging cat...
May 12, 2021
New imaging platform merges optical coherence tomography (OCT) with the power of automation using artificial intelligence (AI)
April 30, 2021
Abbott’s new imaging platform powered by Ultreon 1.0 Software launches in Europe Apr 30 2021 Abbott today announced that its new imaging platform powered by Ultreon 1.0 Software, is now CE Marked in Europe. This first-of-its-kind imaging software merges optical coherence tomography (OCT) – an imaging tool that provides physicians a comprehensive view inside an artery or blood vessel – with the power of artificial intelligence (AI) for enhanced visualization. The new Ultreon Software can a...